3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
2
Metastatic Castration Resistant Prostate Cancer
1
Interventions
tildrakizumab
1
sabizabulin
1
enzalutamide
1
Pluvicto
1
N-(2-(2,3-difluoro-6-benzylthio)-6-(3,4-dihydroxybutan-2-yloxy)pyrimidin-4-yl)azetidine-1-sulfonamide
1
Abiraterone Acetate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Metastatic Castration Resistant Prostate Cancer
×
Pluvicto
×
Clear all
NCT03042312
2021-03-24
RESIST-PC
Endocyte
Phase 2
Terminated
71 enrolled
15 charts